Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Critical Therapeutics Inc (CRTX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Critical Therapeutics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1145404.
Total stock buying since 2010: $118,737,353.
Total stock sales since 2010: $12,330,004.
Total stock option exercises since 2010: $246,967.
▪ Statistics of price movements of CRTX
▪ Recent SEC 13D filings for all companies
▪ Funds & ETFs holding CRTX
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2014 | 11,542,313 | $109,651,973 | 0 | $0 | 0 | $0 |
| 2012 | 1,454,113 | $9,085,380 | 1,507,238 | $9,462,567 | 63,325 | $246,967 |
| 2011 | 0 | $0 | 11,850 | $86,240 | 0 | $0 |
| 2010 | 0 | $0 | 462,029 | $2,781,197 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-02 | 11,542,313 | $109,651,973 | 0 | $0 | 0 | $0 |
| 2012-08 | 0 | $0 | 63,325 | $438,111 | 63,325 | $246,967 |
| 2012-04 | 1,443,913 | $9,024,456 | 1,443,913 | $9,024,456 | 0 | $0 |
| 2012-03 | 10,200 | $60,924 | 0 | $0 | 0 | $0 |
| 2011-07 | 0 | $0 | 2,000 | $17,260 | 0 | $0 |
| 2011-05 | 0 | $0 | 5,850 | $44,460 | 0 | $0 |
| 2011-04 | 0 | $0 | 2,000 | $13,060 | 0 | $0 |
| 2011-01 | 0 | $0 | 2,000 | $11,460 | 0 | $0 |
| 2010-12 | 0 | $0 | 450,000 | $2,709,000 | 0 | $0 |
| 2010-11 | 0 | $0 | 7,900 | $49,612 | 0 | $0 |
| 2010-06 | 0 | $0 | 4,129 | $22,585 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-02-03 | Chiesi Farmaceutici Spa (10% Owner) | Buy | 11,542,313 | 9.50 | 109,651,973 |
| 2012-08-29 | Franklin Joshua B (VP, Strategy & Bus. Dev.) | Sale | 38,637 | 6.86 | 265,049 |
| 2012-08-29 | Franklin Joshua B (VP, Strategy & Bus. Dev.) | Option Ex | 38,637 | 3.90 | 150,684 |
| 2012-08-24 | Franklin Joshua B (VP, Strategy & Bus. Dev.) | Sale | 24,688 | 7.01 | 173,062 |
| 2012-08-24 | Franklin Joshua B (VP, Strategy & Bus. Dev.) | Option Ex | 24,688 | 3.90 | 96,283 |
| 2012-04-03 | Chiesi Farmaceutici Spa (10% Owner) | Buy | 1,443,913 | 6.25 | 9,024,456 |
| 2012-04-03 | Collard Craig A (Chief Executive Officer) | Sale | 1,443,913 | 6.25 | 9,024,456 |
| 2012-03-15 | Chiesi Farmaceutici Spa (10% Owner) | Buy | 3,400 | 6.08 | 20,672 |
| 2012-03-14 | Chiesi Farmaceutici Spa (10% Owner) | Buy | 3,400 | 5.99 | 20,366 |
| 2012-03-12 | Chiesi Farmaceutici Spa (10% Owner) | Buy | 3,400 | 5.85 | 19,886 |
| 2011-07-15 | Powell Andrew Kenneth William (EVP, General Counsel) | Sale | 2,000 | 8.63 | 17,260 |
| 2011-05-26 | Roberts Alan (VP, Scientific Affairs) | Sale | 5,850 | 7.60 | 44,460 |
| 2011-04-04 | Powell Andrew Kenneth William (EVP, General Counsel) | Sale | 2,000 | 6.53 | 13,060 |
| 2011-01-07 | Powell Andrew Kenneth William (EVP, General Counsel) | Sale | 2,000 | 5.73 | 11,460 |
| 2010-12-16 | Lutz Steven Michael (Executive Vice President) | Sale | 65,000 | 6.02 | 391,300 |
| 2010-12-16 | Collard Craig A (President and CEO) | Sale | 385,000 | 6.02 | 2,317,700 |
| 2010-11-01 | Powell Andrew Kenneth William (EVP, General Counsel) | Sale | 7,900 | 6.28 | 49,612 |
| 2010-06-01 | Franklin Joshua B (VP, Sales and Marketing) | Sale | 4,129 | 5.47 | 22,585 |
Insider trading activities including stock purchases, stock sales, and option exercises of CRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Critical Therapeutics Inc (symbol CRTX, CIK number 1145404) see the Securities and Exchange Commission (SEC) website.